Curated News
By: NewsRamp Editorial Staff
August 11, 2026

Stonegate Updates Coverage on Nu Skin After Q2 Miss

TLDR

  • NU Skin's revised guidance signals lower near-term risk, but Prysm iO adoption and cost actions could drive 2027 upside for investors.
  • NU Skin's 2Q26 revenue fell to $320.1M, but adjusted EPS met estimates; gross margin improved 20 bps, while operating margin declined 190 bps.
  • NU Skin's focus on AI-enabled wellness plans and improving sales-force productivity aims to deepen customer engagement and enhance long-term health outcomes.
  • NU Skin's Prysm iO platform has completed 2.5 million scans, with a target of 50,000-60,000 devices placed by year-end.

Impact - Why it Matters

This news matters because Nu Skin Enterprises is undergoing a significant transformation, and the revised guidance and strategic shifts, particularly the delay in India and the focus on Prysm iO, signal both challenges and opportunities. For investors and stakeholders, understanding these changes is crucial for assessing the company's near-term performance and long-term growth potential. The emphasis on AI-driven devices and sales-force productivity could redefine Nu Skin's business model, affecting its competitive position in the beauty and wellness industry. This update provides critical insights into how the company is navigating a difficult market environment and what levers it might pull to return to sustainable growth, making it essential reading for those with an interest in Nu Skin's future.

Summary

Stonegate Capital Partners has updated its coverage on NU Skin Enterprises Inc. (NYSE: NUS), a global beauty and wellness company, following the release of its second-quarter 2026 results. The company reported revenue of $320.1 million, adjusted net income of $10.0 million, and adjusted EPS of $0.20, which matched Stonegate's estimate despite a weaker top line. However, GAAP EPS came in at $(5.14), primarily due to a $78.9 million non-cash goodwill impairment and a $167.5 million deferred-tax valuation allowance, both excluded from adjusted results. Core Nu Skin gross margin improved 20 basis points year-over-year to 77.7%, but consolidated gross margin declined 60 basis points to 68.2%, and adjusted operating margin fell 190 basis points to 6.1%. Revenue declined 15.5% for Nu Skin and 25.0% for Rhyz, the company's manufacturing and technology segment. Management also reduced its full-year 2026 revenue guidance to $1.28B-$1.35B from a previous range of $1.35B-$1.50B, and adjusted EPS guidance to $0.70-$0.90 from $0.80-$1.20. Additionally, the launch in India has been pushed to the first half of 2027 as the company refines local sourcing, logistics, technology integration, and its affiliate model. To view the full announcement, including downloadable images, bios, and more, click here.

Despite the lowered guidance, Stonegate highlights several positive developments. Prysm iO, the company's AI-powered beauty and wellness device, remains a central longer-term growth initiative, with more than 39,000 devices placed and 2.5 million scans completed, targeting 50,000-60,000 devices by year-end. Stonegate views Prysm iO as a sales-force productivity tool, with AI-enabled assessments, recommendations, and 90-day wellness plans expected to help leaders deepen customer engagement, improve conversion, and broaden monetization across beauty and wellness. Sales-force trends showed early signs of stabilization, with sales leaders down only 9% year-over-year versus a 13% decline in the first quarter, and essentially flat quarter-over-quarter. Mainland China sales leaders increased 2% year-over-year. Although recruiting remains below levels required for sustainable growth and India has shifted to the first half of 2027, Prysm iO training, compensation changes, leadership development initiatives, and the East-West operating model provide several potential drivers for improved productivity and profitability next year.

Source Statement

This curated news summary relied on content distributed by Reportable. Read the original source here, Stonegate Updates Coverage on Nu Skin After Q2 Miss

Blockchain registration record for this content